Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia & GRAPEVINE, Texas–(BUSINESS WIRE)–Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that on April 14, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to … [Read more…]

Align Technology Recognized for the Fifth Consecutive Year as a LexisNexis Top 100 Global Innovator, Earning “Five-Year Top 100 Global Innovator” Distinction

TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align has again been recognized, for the fifth consecutive year, as a Top 100 Global … [Read more…]

Wisconsin Supreme Court Sides with Family in Asbestos Case Against Pabst Brewing Co.

Decision reinforces workplace safety obligations for companies and contractors on-site MILWAUKEE–(BUSINESS WIRE)–The Wisconsin Supreme Court has affirmed that Pabst Brewing Co. can be held liable for asbestos exposure at its Milwaukee brewery, marking the latest development in long-running litigation brought by the family of a steamfitter who died from mesothelioma. The case was decided in … [Read more…]

SurGenTec Secures FDA 510(k) Clearance for TiLink™ SI joint fusion- Now Navigation Compatible

BOCA RATON, Fla.–(BUSINESS WIRE)–$ISRG #FDAcleared–SurGenTec, LLC, a leader in innovative spine and orthopedic technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its TiLink™ Navigation Instruments for use with the TiLink™ SI Joint Fusion System in sacroiliac joint procedures. The system is engineered for compatibility with Medtronic’s StealthStation™ … [Read more…]

Pangea Pharmaceuticals Announces U.S. Launch of Sdamlo™, the First and Only FDA-Approved, Amlodipine Powder for Oral Solution

Unit-dose, alcohol-free formulation designed to support precise dosing and ease of administration across pediatric, geriatric, dysphagic, and institutional care settings FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–#amlodipine—Pangea Pharmaceuticals, a U.S.-based, patient-centered pharmaceutical company focused on bringing differentiated, clinically relevant products to market, today announced the U.S. launch of Sdamlo™ (amlodipine for oral solution), the first and only FDA-approved, … [Read more…]

Alloy Therapeutics Announces $40M Series E to Scale Tech-Enabled Biotech Infrastructure

– Today, Alloy has over 200 partners with over 100 licensed therapeutic programs, including 22 in clinical development – Powered by AI integrated with real-world data and wet lab execution, Alloy delivers a faster, more capital-efficient path from idea to clinic BOSTON–(BUSINESS WIRE)–Alloy Therapeutics, Inc. (“Alloy”), a biotechnology ecosystem company powering the future of drug … [Read more…]

Grindr for Equality Launches Out in the Open, A New Series Connecting the LGBTQ+ Community to the Conversations that Matter

Grindr for Equality Presents: Out in the Open with You Are Loved, the first installment focused on chemsex LONDON–(BUSINESS WIRE)–$GRND—Grindr for Equality, the global social impact initiative of Grindr, the world’s largest social networking app for gay, bi, trans, and queer people, launches Out in the Open, a new content series that does what Grindr … [Read more…]

HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock

Offering is being led by HeartBeam’s first commercial customer, ClearCardio™, the Company’s executive leadership, board members, and existing investors SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the pricing of its underwritten public offering of 12,500,000 shares of its common … [Read more…]

Prime Healthcare Earns Unanimous Approval, Community Support for Expansion Across Illinois with Olympia Fields

Applauded by community leaders for commitment to access, care, quality and social responsibility ONTARIO, Calif. & OLYMPIA FIELDS, Ill.–(BUSINESS WIRE)–#AccessToCare–Prime Healthcare received unanimous approval today from the Illinois Health Facilities and Services Review Board for the purchase of Franciscan Health Olympia Fields. The 8-0 vote reflects confidence in Prime Healthcare’s proven ability to strengthen hospitals, … [Read more…]

The Biggest Names in Wearables Are Racing Toward Muscle Oxygenation Measurements; NNOXX Already Has the Platform

A patented near-infrared spectroscopy (NIRS) platform, clinically validated muscle oxygenation measurement (SmO₂), dual nitric oxide sensing, and an AI-powered training platform position NNOXX as the fastest path to category leadership in performance wearables. KEY HIGHLIGHTS — Two of the largest wearable platforms have made public moves toward muscle oxygen measurement. One filed an SmO₂ trademark. … [Read more…]